Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v6-EN
Language English English
Date Updated 2018-03-14 2017-11-06
Drug Identification Number 02314290 02314290
Brand name TEVA-NARATRIPTAN TEVA-NARATRIPTAN
Common or Proper name NARATRIPTAN NARATRIPTAN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients NARATRIPTAN NARATRIPTAN
Strength(s) 1MG 1MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 8 8
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2015-10-15 2015-10-15
Estimated end date 2018-02-28 2018-02-28
Actual end date 2018-03-13
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments